Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

NCT01445379

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

The Second Multicenter Hemophilia Cohort Study

NCT00341705

Conditions
Acquired Immunodeficiency Syndrome, Adenocarcinoma, Blood Coagulation Disorders, +46 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of California, Davis Davis, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer

NCT01445522

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details

Related conditions